trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Goldenhar Syndrome D006053 1 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Supratentorial Neoplasms D015173 1 associated lipids
Myopathy, Central Core D020512 1 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Adenomyosis D062788 1 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Ohtani K et al. Epigenetic regulation of endothelial lineage committed genes in pro-angiogenic hematopoietic and endothelial progenitor cells. 2011 Circ. Res. pmid:21980126
Hagiwara H et al. Histone deacetylase inhibitor trichostatin A enhances myogenesis by coordinating muscle regulatory factors and myogenic repressors. 2011 Biochem. Biophys. Res. Commun. pmid:22019851
Jafari S et al. Epigenetic modification does not determine the time of POU5F1 transcription activation in cloned bovine embryos. 2011 J. Assist. Reprod. Genet. pmid:22020531
Tseng AS et al. HDAC activity is required during Xenopus tail regeneration. 2011 PLoS ONE pmid:22022609
Rajak H et al. 2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors. 2011 Bioorg. Med. Chem. Lett. pmid:21875796
He HM et al. [The effects of a histone deacetylase (HDAC) inhibitor on endotoxin-induced endothelial cell injury]. 2011 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:22005560
Sanders YY et al. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. 2011 Am. J. Respir. Cell Mol. Biol. pmid:20724553
Chik CL et al. Histone modifications on the adrenergic induction of type II deiodinase in rat pinealocytes. 2011 Mol. Cell. Endocrinol. pmid:21704117
Zhang L et al. ABA treatment of germinating maize seeds induces VP1 gene expression and selective promoter-associated histone acetylation. 2011 Physiol Plant pmid:21679193
Lin S et al. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells. 2011 Curr. HIV Res. pmid:21631428
Jugová A et al. Effects of epigenetic-based anti-cancer drugs in leukaemia and multiple myeloma cells. 2011 Cell Biol. Int. pmid:21635225
Wong CY et al. Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells. 2011 J. Biol. Chem. pmid:21636851
Hayashi-Takanaka Y et al. Tracking epigenetic histone modifications in single cells using Fab-based live endogenous modification labeling. 2011 Nucleic Acids Res. pmid:21576221
Bouquet F et al. A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia. 2011 J. Cell. Sci. pmid:21576354
Hawk JD et al. Post-training intrahippocampal inhibition of class I histone deacetylases enhances long-term object-location memory. 2011 Learn. Mem. pmid:21576516
Dong X et al. Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells. 2011 Endocr. Relat. Cancer pmid:21367844
Yang J et al. [Study of RASSF1A expression and promoter demethylation in Hep-2 cell line]. 2011 Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi pmid:21473137
Cui XS et al. Trichostatin A modulates apoptotic-related gene expression and improves embryo viability in cloned bovine embryos. 2011 Cell Reprogram pmid:21473694
Chen X et al. Design, synthesis and biological evaluation of hydroxamic acid derivatives as potential high density lipoprotein (HDL) receptor CLA-1 up-regulating agents. 2011 Molecules pmid:22048700
Sun JY et al. Histone deacetylase inhibitors demonstrate significant preclinical activity as single agents, and in combination with bortezomib in Waldenström's macroglobulinemia. 2011 Clin Lymphoma Myeloma Leuk pmid:21454220
Kong QR et al. [TSA improve transgenic porcine cloned embryo development and transgene expression]. 2011 Yi Chuan pmid:22049689
Min XJ et al. Dysfunction of volume-sensitive chloride channels contributes to cisplatin resistance in human lung adenocarcinoma cells. 2011 Exp. Biol. Med. (Maywood) pmid:21454376
Belakavadi M et al. Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events. 2011 Mol. Cell. Endocrinol. pmid:21458529
Zelko IN et al. Histone acetylation regulates the cell-specific and interferon-γ-inducible expression of extracellular superoxide dismutase in human pulmonary arteries. 2011 Am. J. Respir. Cell Mol. Biol. pmid:21493784
da Costa Prando E et al. Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines. 2011 Epigenetics pmid:22139571
Kretzner L et al. Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels. 2011 Cancer Res. pmid:21502403
Poplineau M et al. Raman microspectroscopy detects epigenetic modifications in living Jurkat leukemic cells. 2011 Epigenomics pmid:22126296
Qiu GH et al. Recognition and suppression of transfected plasmids by protein ZNF511-PRAP1, a potential molecular barrier to transgene expression. 2011 Mol. Ther. pmid:21540836
Wang QS et al. [Silence mechanism of WT1 gene in leukemic cell line U937]. 2011 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:22040952
Fu S et al. Involvement of histone acetylation of Sox17 and Foxa2 promoters during mouse definitive endoderm differentiation revealed by microRNA profiling. 2011 PLoS ONE pmid:22132182
Kumar A et al. γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines. 2011 Int. J. Radiat. Biol. pmid:21815748
Tan L et al. Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells. 2011 Cancer pmid:20925046
Jackson K et al. Epigenetic silencing of somatostatin in gastric cancer. 2011 Dig. Dis. Sci. pmid:20927589
Sahu GK and Cloyd MW Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors. 2011 Virol. J. pmid:21838863
Yu D et al. Clonal Rett Syndrome cell lines to test compounds for activation of wild-type MeCP2 expression. 2011 Bioorg. Med. Chem. Lett. pmid:21840716
Atanackovic D et al. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia. 2011 Am. J. Hematol. pmid:21898529
Paterson S et al. Histone deacetylase inhibitors increase human arylamine N-acetyltransferase-1 expression in human tumor cells. 2011 Drug Metab. Dispos. pmid:20870783
Wang JP et al. Recapitulation of fibromatosis nodule by multipotential stem cells in immunodeficient mice. 2011 PLoS ONE pmid:21901157
Nakaya Y et al. Epigenetic regulation on the 5'-proximal CpG island of human porcine endogenous retrovirus subgroup A receptor 2/GPR172B. 2011 Microbes Infect. pmid:20951222
Robers MB et al. Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology. 2011 Mol Biosyst pmid:20931131
Hsu YF et al. MAPK phosphatase-1 contributes to trichostatin A inhibition of cyclooxygenase-2 expression in human umbilical vascular endothelial cells exposed to lipopolysaccharide. 2011 Biochim. Biophys. Acta pmid:21911040
Stoppani E et al. Point mutated caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature. 2011 Biochim. Biophys. Acta pmid:21182936
Puppin C et al. Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. 2011 Oncol. Rep. pmid:21152868
Tsai PF et al. Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation. 2011 J. Virol. pmid:21159880
Nandakumar V et al. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. 2011 Carcinogenesis pmid:21209038
Kang H and Roh S Extended exposure to trichostatin A after activation alters the expression of genes important for early development in nuclear transfer murine embryos. 2011 J. Vet. Med. Sci. pmid:21187677
Mitmaker EJ et al. Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors. 2011 Surgery pmid:21193210
Liao M et al. Coactivator function of positive cofactor 4 (PC4) in Sp1-directed luteinizing hormone receptor (LHR) gene transcription. 2011 J. Biol. Chem. pmid:21193408
Erb TM et al. Paracrine and epigenetic control of trophectoderm differentiation from human embryonic stem cells: the role of bone morphogenic protein 4 and histone deacetylases. 2011 Stem Cells Dev. pmid:21204619
Host L et al. Cocaine self-administration alters the expression of chromatin-remodelling proteins; modulation by histone deacetylase inhibition. 2011 J. Psychopharmacol. (Oxford) pmid:19939859